Results 31 to 40 of about 8,923 (197)

Biomarkers of ‘acute-onset’ chronic inflammatory demyelinating polyneuropathy [PDF]

open access: yesBrain, 2014
Sir, We read with great interest the article by Sung et al. (2014) reporting the usefulness of nerve excitability testing in differentiating acute-onset chronic inflammatory demyelinating polyneuropathy (A-CIDP) from acute inflammatory demyelinating polyneuropathy (AIDP).
Yumako, Miura   +2 more
openaire   +2 more sources

Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans [PDF]

open access: yes, 2010
Background: Sudden limb paresis is a common problem in White Leghorn flocks, affecting about 1% of the chicken population before achievement of sexual maturity.
Sascha Trapp   +26 more
core   +1 more source

Anti-Neurofascin–Associated Nephrotic-Range Proteinuria in Chronic Inflammatory Demyelinating Polyneuropathy

open access: yesKidney Medicine, 2020
There are few case reports of concomitant chronic inflammatory demyelinating polyneuropathy (CIDP) and focal segmental glomerulosclerosis. A rare autoantibody to a neuronal and podocyte structural component, neurofascin, may be contributory.
Syed Bukhari   +5 more
doaj   +1 more source

Acute sensory inflammatory demyelinating polyneuropathy and central diabetes insipidus

open access: yesНеврология, нейропсихиатрия, психосоматика, 2021
Guillain-Barre syndrome (GBS) is characterized by acute, progressive monophasic course with a predominance of motor disorders in typical cases; it develops due to an aberrant immune response in some viral and bacterial infections.
T. G. Sakovets, E. I. Bogdanov
doaj   +1 more source

Axonal excitability findings in acute inflammatory demyelinating polyneuropathy related to SARS-CoV-2

open access: yesNeurological Sciences and Neurophysiology, 2022
Guillain–Barré syndrome (GBS) is a disorder of the peripheral nervous system characterized by acute-onset ascendance paresis. We present a patient who was diagnosed as having facial-onset acute inflammatory demyelinating polyneuropathy after being ...
Abir Alaamel   +6 more
doaj   +1 more source

Reply: Biomarkers of ‘acute-onset’ chronic inflammatory demyelinating polyneuropathy [PDF]

open access: yesBrain, 2014
Sir, ‘In my end is my beginning’ ∼ T.S. Eliot, East Coker In keeping with the quotation by T.S. Eliot, the clear delineation of CIDP phenotypic variants remains a difficult and often circular process. The search for antigenic targets in CIDP has continued for almost 30 years, but to date there is still no well-defined link between molecular ...
Susanna B, Park   +4 more
openaire   +2 more sources

Characteristics of COVID and post COVID polyneuropathies in adults and pediatrics: an Egyptian sample

open access: yesThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2021
Background The aim of this study is to describe the different forms of polyneuropathy associated with coronavirus disease 2019 (COVID-19) as a secondary neurological complication for (COVID-19) and the outcome from different therapeutic regimens in ...
Haidy Elshebawy   +2 more
doaj   +1 more source

Guillain-​Barré Syndrome Associated with COVID-19 Vaccination

open access: yesEmerging Infectious Diseases, 2021
We conducted a multi-institutional study in Taiwan and a systematic review of the literature for reports of Guillain-​Barré syndrome after coronavirus disease vaccination.
Shih-Chieh Shao   +5 more
doaj   +1 more source

Epidemiologic and Clinical Characteristics of Guillain-Barré Syndrome in Patients Referred to Sina Hospital in Hamadan in 2018 [PDF]

open access: yesInternational Journal of Epidemiologic Research, 2022
Background and aims: Guillain-Barré syndrome (GBS) has several types, some of which damage myelin and some others cause axonal damage. Detecting the type of GBS is important in determining the type of treatment and its prognosis. This study was conducted
Mojtaba Khazaei   +4 more
doaj   +1 more source

Chronic inflammatory demyelinating polyneuropathy after chadox1 ncov-19 vaccination

open access: yes, 2021
Recently several patients, who developed Guillain–Barré syndrome characterized by prominent bifacial weakness after ChAdOx1 nCoV-19 vaccination, were described from different centers.
Zara P.   +6 more
core   +2 more sources

Home - About - Disclaimer - Privacy